XPNPEP3: A Protein Regulating Lipid Metabolism and Inflammation

Target Name: XPNPEP3

NCBI ID: G63929

XPNPEP3

XPNPEP3: A Protein Regulating Lipid Metabolism and Inflammation

XPNPEP3 (NPHPL1) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the NPHPL family, which includes several related proteins that play a role in the regulation of lipid metabolism and the transport of lipids to the liver for energy storage.

One of the unique features of XPNPEP3 is its ability to interact with other proteins that are expressed in the brain, including the protein known as Transthyretin (Ttr). Ttr is a protein that is expressed in the brain and is involved in the transport of lipids to the brain for energy storage. By interacting with Ttr, XPNPEP3 is able to regulate the amount of lipids that are transported to the brain, which is important for maintaining the health and function of the brain.

In addition to its role in lipid metabolism, XPNPEP3 is also involved in the regulation of inflammation. Many studies have suggested that XPNPEP3 is involved in the regulation of inflammation in the brain, which is important for maintaining the health and function of the brain.

Despite its importance for a variety of physiological processes, XPNPEP3 is not yet a well-studied protein. There are currently limited research studies that have focused on its role in the regulation of lipid metabolism, inflammation, and other physiological processes.

In conclusion, XPNPEP3 is a protein that is expressed in various tissues of the body and is involved in the regulation of lipid metabolism and inflammation. While more research is needed, its potential as a drug target or biomarker is significant. Further studies are needed to fully understand its role in the regulation of lipid metabolism and inflammation, and to determine its potential as a therapeutic intervention.

Protein Name: X-prolyl Aminopeptidase 3

Functions: Catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Leu-Pro-Ala (PubMed:25609706, PubMed:28476889). Also shows low activity towards peptides with Ala or Ser at the P1 position (PubMed:28476889)

The "XPNPEP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XPNPEP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets